Picture EBD Group BIO-Europe Spring 2016 BES Stockholm Sweden April 600x60px
All >

Deals > Germany

Find below collaborations, license and distribution agreements, grants, investments and loan agreements from Germany or involving German organisations.

Total search results: 6710 | Ordered by Date (descending)
next pagenext page 1 2 3 4 ... 66 67 68  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Insilico Biotechnology–SEVERAL: investment, 201507 capital increase 2015-07-10
JeNaCell–Evonik: investment, 201507 financing round Series A incl new investor Evonik Industries 2015-07-09
JeNaCell–High-Tech Gründerfonds: investment, 201507 financing round Series A incl existing investor HTGF 2015-07-09
JeNaCell–SEVERAL: investment, 201507 financing round Series A from Evonik + bm-t + Sparkasse Jena + HTGF + STIFT 2015-07-09
Qiagen–Seegene: molecular diagnostics, 201507– collab ww marketing validated multi-plexed Seegene PCR tests for QIAsymphony RGQ MDx system 2015-07-08
Cellca–Sartorius: investment, 201507 acquisition of Cellca GmbH by Sartorius Stedim Biotech 2015-07-02
Neovacs–MC Services: public relations, 201507 service existent by MC Services IR in Germany 2015-07-02
Biotest–Cevec: rec protein production technology, 201507– license to CAP Go technology to Biotest AG 2015-07-01
GNA Biosolutions–Instinctif Partners: public relations, 201507 service existent by Instinctif Partners 2015-07-01
GNA Biosoutions–SEVERAL: investment, financing round Series B €6m led by new investor Robert Bosch Venture Capital GmbH 2015-07-01
Qiagen–Zörgiebel Group: molecular diagnostics, 201506– collab founding joint venture Biotye Innovation GmbH to develop MDx companion diagnostics 2015-06-26
BioNTech–Siemens: cancer vaccine, 201506– collab developm + construction automated production facility for IVAC products Siemens Process Automation 2015-06-25
BioNTech–Strüngmann Group: investment, 201506 existent Strüngman family office is majority shareholder of BioNTech AG 2015-06-25
Ankasa Regenerative–Heraeus: investment, 201506 financing round Series A 1st tranche totalling $8.5m of $17m Series A incl Heraeus Medical 2015-06-23
4SC–SEVERAL: investment, 201506–201507 cash capital increase €29m with 7.25m new shares at €4/share 2015-06-22
4SC–Strüngmann Group: investment, 201506–201507 capital increase €6m in kind 1.5m new shares at €4/share swapping part of shareholder loan from Santo 2015-06-22
4SC–Wellington Partners: investment, 201506–201507 cash capital increase totalling €29m incl €5m from Wellington 2015-06-22
Univ California–Scienion: automated liquid handling, 201506 supply existent Gianneschi Group at UCSD is early user of sciTEM system 2015-06-22
ChemAxon–BSSN Software: cheminformatics, –201506 collab developm Mass Spec Add-on for Instant JChem using Seahorse Scientific Workbench s/w platform 2015-06-18
Pierre Fabre–Biomax: bioinformatics, 201506– license to BioXM Knowledge Management Environment + collab database development 2015-06-18
Qiagen–Hitachi: genomic testing systems, 201506– collab strategic alliance €na developm PCR + NGS based automation systems for research + IVD 2015-06-18
Affiris–MIG Fonds: investment, 201506 financing round €10m equally subscribed by major investors Santo Holding + MIG Funds 2015-06-16
Affiris–Strüngmann Group: investment, 201506 financing round €10m equally subscribed by major investors Santo Holding + MIG Funds 2015-06-16
Medigene–BIO (US): trade fair, 201506 supply service Medigene participates in BIO 2015 2015-06-15
Medigene–SEVERAL: investment, 201506 capital increase €46.4m with 5.6m news shares at €8.3/share 2015-06-12
BioNTech–Stratifyer: molecular diagnostics, –201506 collab developm of RT-qPCR based MammaTyper test 2015-06-11
JnJ–Max Planck: drug discovery services, 201506– collab 2y of LDC with JnJ Innovation Centre London 2015-06-11
OmicScouts–Pelago Bioscience: drug discovery technology, 201506– license + collab developm €na CETSA method for mass spec-based proteomics 2015-06-10
OTHER–AMP Biosimilars: biopharmaceutical, 201506– license for biogeneric humanised MAb ABY-021 in China to mid-sized Chinese pharma company 2015-06-10
Alpha Laboratories–Eppendorf: gradient PCR technology, 201506 license to Patent EP1426110B1 to Alpha Laboratories Ltd 2015-06-09
QuantuMDx–Scienion: print/spotting technology, 201506 supply purchase sciFlexarrayer SX to transfer biological material on Q-POC biosensor 2015-06-09
Thermo Fisher–Eppendorf: gradient PCR technology, 201506 license to Patent EP1426110B1 to Life Technologies Corp 2015-06-09
Qurient–Max Planck: kinase inhibitor, 201506– license ww excl to CDK7 inhibitors from LDC + start of broader collaboration 2015-06-03
Affimed–Jefferies: investment conference, 201506 supply service Affimed presents at Global Healthcare Conference 2015-06-01
Apogenix–Jefferies: investment conference, 201506 supply service Apogenix presents at Global Healthcare Conference 2015-06-01
Cevec–MC Services: public relations, 201506 service existent by MC Services AG 2015-06-01
EYE-RISK project–Ayoxxa: biomarker discovery, 201506–2019 Ayoxxa is industry partner in Horizon 2020 project to study factors for developing AMD 2015-06-01
EYE-RISK project–EU (govt): grant, 201506–2019 Horizon 2020 grant €6m to study factors for developing AMD 2015-06-01
Helmholtz–Bruker Corp: mass spectrometer, 201506 supply existent MALDI Tissuetyper Axel Walch at Helmholtz-Center in Munich is among early users 2015-06-01
Immuno-Transporter project–Germany (govt): grant, 201506– BMBF grant funding €3.8m over 3 years to develop cancer-immunotherapies 2015-06-01
LabCorp–Sysmex: molecular diagnostics, 201506– strategic alliance of Sysmex Inostics + Covance to support personalised drug developm 2015-06-01
MVZ Dortmund–Bruker Corp: mass spectrometer, 201506 supply existent use of MALDI Biotyper by MVZ Dortmund Dr Eberhard + Partner 2015-06-01
PRECIOUS project–CTC North: clinical research, 201506–202006 CTC North GmbH & Co KG is partner in Horizon 2020 project on stroke in elderly patients 2015-06-01
PRECIOUS project–Univ Hamburg: clinical research, 201506–202006 UKE is partner in Horizon 2020 project on stroke in elderly patients 2015-06-01
SeedWorks India–Bayer: investment, 201506 acquisition €na by Bayer CropScience 2015-06-01
Univ Maastricht–Bruker Corp: mass spectrometer, 201506 supply existent MALDI Tissuetyper Ron Heeren at M4I Institute is among early users 2015-06-01
Boehringer–Univ Michigan: drug discovery, 201505– collab research €na to discover new drugs for diabetic nephropathy 2015-05-28
OTHER–AMP Biosimilars: biopharmaceutical, 201505– license for biogeneric ABY-018 in China to mid-sized Chinese pharma company 2015-05-28
Boehringer–Eureka Therapeutics: antibody cancer drug, 201505– collab drug discovery €na 2015-05-21
Affimed–UBS: investment conference, 201505 supply service Affimed NV presents at UBS 2015 Global Healthcare Conference 2015-05-19
Forbion–Germany (govt): investment, 201505 KfW invests into FCF III life science fund with new ERP VC Fund Investments 2015-05-19
Genmab–BioNTech: cancer immunotherapy, 201505– collab $10m upfront fee developm + commercialisation bispecific antibodies 2015-05-19
Medigene–Informa: investment conference, 201505 supply service Medigene participant at BioEquity Europe 2015 in Vienna 2015-05-19
Boehringer–Pharmaxis: SSAO/VAP-1 inhibitors, 201505 acquistion global rights €27.5m upfront + milestones to PXS4728A + related compounds by BI 2015-05-18
Comprehensive Biomarker Center–Agilent: microarray technology, 201505 supply existent CBC is Agilent Certified Microarray Service Provider 2015-05-15
BioNTech–Hume Brophy: public relations, 201505 service existent by Hume Brophy 2015-05-11
BioNTech–Lilly: investment, 201505 equity investment $30m in BioNTech Cell & Gene Therapies GmbH as part of collab 2015-05-11
Epigenomics–SEVERAL: investment, 201505 capital increase €5m placing 976.6k new shares at €5.12 to existing shareholders 2015-05-11
Lilly–BioNTech: cancer immunotherapy, 201505– research collab $30m upfront + $300m milestones + royalties 2015-05-11
Stage Cell Therapeutics–Juno Therapeutics: investment, 201505 acquisition remaining 95% for €52.5m cash upfront + 486.3k shares + €135m milestones 2015-05-11
Lanthio Pharma–MorphoSys: investment, 201505 acquisition of remaining 80% of shares for €20m from other investors by MorphoSys AG 2015-05-07
Themis Bioscience–Wellington Partners: investment, 201505 financing round Series B 1st closing totalling €7m incl new + led investor Wellington 2015-05-05
Affimed–SEVERAL: investment, 201505 public offering $45.71m net $37.1m with 5m+750k common shares at $7.15/share 2015-05-04
Bayer–Isis Pharmaceuticals: factor XI inhibitor, 201505– license excl $100m upfront + milestones + tired royalties to ISIS-FXIRx 2015-05-04
Cambridge Bioscience–Genetrix (ES): genomic reagents, 201505– distribution non-excl Sygnis TruePrime + SunScript RT products in UK + IE 2015-05-04
Merck (DE)–Genea Biomedx: IVD technology, 201505– collab ww marketing rights €na for Gavi + Geri + Gems + future product lines for Merck Serono 2015-05-01
Cytena–High-Tech Gründerfonds: investment, 201504 seed financing round totalling €1.1.m from HTGF + a private investor 2015-04-29
Cytena–SEVERAL: investment, 201504 seed financing round €1.1.m from HTGF + a private investor 2015-04-29
Epigenomics–EU (govt): grant, 201504– Horizon 2020 grant €2.77m to validate lung cancer biomarkers in blood plasma 2015-04-29
Facio Therapies–Evotec: drug discovery services, 201504– supply screening service €na to identify drug for muscular wasting disease FSHD 2015-04-29
Univ Utrecht–Bruker Corp: mass spectrometer, 201504 supply existent UMC Utrecht has beeen using MALDI Biotyper for years 2015-04-27
Biofrontera–SEVERAL: investment, 201504–201505 open offer + private placement €3.1m w 2.173m new shares at €2.3/share 2015-04-23
Univ Oslo–Medigene: DC vaccine, 201504 collab existent compassionate use in academic clinical studies in solid tumours by Oslo Univ Hospital 2015-04-20
Medigene–Kempen: investment conference, 201504 supply service Medigene participant at Kempen & Co Healthcare + Life Sciences Conference in NY 2015-04-16
Omeicos Therapeutics–MacDougall Biomedical Communications: public relations, 201504 service existent by MacDougall 2015-04-15
Omeicos Therapeutics–SEVERAL: investment, 201504 financing round Series A €6.2m led by Vesalius Biocapital II 2015-04-15
Boehringer–Hydra Biosciences: TRP inhibitors, 201504– collab drug discovery small-molecule TRP inhibitors for renal diseases 2015-04-13
Accovion–Clinipace: investment, 201504 acquisition of Accovin from HeidelbergCapital + Creathor Venture + management 2015-04-10
Biofrontera–Maschmeyer Group: investment, 201404 DIVESTMENT Maschmeyer sells 1m remaining shares to existing institutional investors of Biofrontera 2015-04-08
CRISPR Therapeutics–MacDougall Biomedical Communications: public relations, 201504 service existent by MacDougall 2015-04-07
Merck (DE)–Pfizer: cancer drug, 201504– co-promotion of Xalkori in US + CA + JP + FR + DE + IT + ES + GB by Merck 2015-04-07
Wilex–SEVERAL: investment, 201504 capital increase €4.16m with 1.5m new shares €2.8/share 2015-04-07
AMP Biosimilars–MC Services: public relations, 201504 service existent by MC Services AG 2015-04-02
Innovative Medicines Initiative–Bayer: cancer biomarker, 201504– collab Bayer HealthCare is coordinating partner of CANCER-ID project 2015-04-01
Innovative Medicines Initiative–Univ Hamburg: cancer biomarker, 201504– collab UKE is coordinating partner of CANCER-ID project 2015-04-01
Merck (DE)–Medicines for Malaria Venture: antimalarial drug, 201504– acquisition rights to DDD107498 by Merck Serono 2015-04-01
Sanofi–Evotec: investment, 201504 acquisition of Sanofi’s site in Toulouse renamed Evotec (France) SAS 2015-04-01
Univ Bayreuth–Bruker Corp: NMR magnet, 201504 supply installation of Ascend Aeon 900 MHz magnet at Research Center for Bio-Macromolecules 2015-04-01
Bayer–MIT: personalised cardiovascular drugs, 201503– collab €na cardiovascular genomics + drug discovery with Broad Institute 2015-03-31
Sonormed–Hamburg (govt): investment, 201503 financing round Series A co-led by HTGF + Innovationsstarter Fonds Hamburg 2015-03-31
Sonormed–High-Tech Gründerfonds: investment, 201503 financing round Series A co-led by HTGF + Innovationsstarter Fonds Hamburg 2015-03-31
Sonormed–SEVERAL: investment, 201503 financing round Series A co-led by HTGF + Innovationsstarter Fonds Hamburg 2015-03-31
AbbVie–BioMed X: pharma research, 201503– collab €na new BioMed X research group to discover Alzheimer’s treatment 2015-03-30
Merck (DE)–Intrexon: cancer immunotherapy, 201503– collab + license excl $115m upfront + $826m milestones + royalties CAR-T cancer therapies 2015-03-30
Analytik Jena–SEVERAL: investment, 201503 DELISTING from regulated market of Frankfurt Stock Exchange 2015-03-26
Apceth–MacDougall Biomedical Communications: public relations, 201503 service existent by MacDougall Munich Office 2015-03-26
Asahi Kasei–Evotec: drug discovery, 201503– supply service €na screening for inhibitors of ion channel targets 2015-03-26
Rigontec–Forbion: investment, 201503 financing round Series A 2nd closing totalling €4.8m from Forbion Capital + Sunstone Capital 2015-03-24
Rigontec–SEVERAL: investment, 201503 financing round Series A 2nd closing €4.8m from Forbion Capital + Sunstone Capital 2015-03-24
Rigontec–Sunstone Capital: investment, 201503 financing round Series A 2nd closing totalling €4.8m from Forbion Capital + Sunstone Capital 2015-03-24
next pagenext page 1 2 3 4 ... 66 67 68  next pagenext page



Picture EBD Group BIO-Europe Spring 2016 BES Stockholm Sweden April 600x60px

To subscribe to our free, monthly newsletter for the life sciences in German-speaking Europe (DE, AT & CH), please send an e-mail to info@iito.de and simply fill the subject line with the word »LSG newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Banner BIO Deutschland CFO-Gipfel 2016 Berlin March 600x60px

» top

Picture EBD Group BIO-Europe Spring 2016 BES Stockholm Sweden April 120x180px Picture B3C Group GmbH First Biotech Pharma Medtech Diagnostics Newswire 120x180 Banner BIO Deutschland CFO-Gipfel 2016 Berlin March 120x240px Picture EBD Group ChinaBio Partnering Forum 2016 CBPF Suzhou May 120x180px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px